Navigation Links
Healthplace America Engages Robert A. Yungk to Provide Services as Chief Strategy Officer
Date:4/7/2009

he has served as a senior executive at UnitedHealth Group and WellPoint.

About Healthplace America

Healthplace America offers the first and only comprehensive Surgery Benefit Management(TM) solution for employer health plans. Its innovative product, the Healthplace Surgery Benefit(TM), provides cost and quality management for the otherwise unmanaged $700 billion surgery industry.

The Healthplace Surgery Benefit(TM) is a specialty referral network of premier hospitals and doctors throughout the U.S. combined with the administrative, case management, communication, and logistics services to connect these providers with health plans and their members. Members also receive personalized attention from a dedicated Personal Care Coordinator who guides them through the entire surgical process, including collecting and storing medical records and arranging for travel and lodging. Unlike HMOs/PPOs and managed care, the Healthplace Surgery Benefit(TM) delivers both cost savings and enhanced care quality through unlocking competition among top medical providers. The Healthplace Surgery Benefit(TM) allows plan sponsors to reduce overall healthcare costs while actually enhancing benefits for their members.

Healthplace America is headquartered in suburban Chicago. Learn more by visiting www.HealthplaceAmerica.com or calling toll-free at 866-964-6401.

Healthplace America is funded in part by Ziegler HealthVest Partners, LP, a venture capital fund investing in early to middle-stage healthcare support services, healthcare IT and wellness.


'/>"/>
SOURCE Healthplace America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Cartesian Gridspeed Opens Subsidiary Operation in North America
3. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
4. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
5. American Oriental Bioengineering Announces Participation in September Investor Conferences
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
8. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
9. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
10. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
11. DaVita to Present at UBS Best of Americas Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2013 was a banner year of ... They saw continued independent research led by the team ... a $1 million grant from the Susanne Marcus Collins ... a peer reviewed journal, Amy Grant highlighted Brainwave Optimization® ...
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, Limited ... agreement with R-Pharm, a leading Russian pharmaceutical company, to ... Russian Federation , Turkey ... States (CIS). Nemonoxacin is a novel antibiotic for the treatment ...
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Association for Cancer Research ... ... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announced that it presented ... at the 2008 American Association for Cancer Research (AACR),Annual Meeting. ...
... April 15, THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND ... OR PURCHASE ANY,SECURITIES REFERRED TO IN THIS ANNOUNCEMENT ... IN THE PROSPECTUS EXPECTED TO BE PUBLISHED BY,SHIRE ... PROSPECTUS WILL,BE PUBLISHED AND MADE AVAILABLE ON SHIRE,S ...
... 14 Symmetry Medical Inc.,(NYSE: SMA ), a ... industry and other medical markets, today announced that,the filing ... the Securities and,Exchange Commission will be delayed beyond its ... in the final stages and the work is,substantially completed. ...
Cached Biology Technology:ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 2ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 3ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 4ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 5Shire to Introduce a New UK Listed Holding Company 2Shire to Introduce a New UK Listed Holding Company 3Shire to Introduce a New UK Listed Holding Company 4Shire to Introduce a New UK Listed Holding Company 5Shire to Introduce a New UK Listed Holding Company 6Shire to Introduce a New UK Listed Holding Company 7Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target 2Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target 3
(Date:7/9/2014)... co-authored by a University of Guelph scientist that ... shows long-term exposure to a neonicotinoid pesticide hampers ... research by Nigel Raine, a professor in Guelph,s ... Imperial College London was published July 9 in ... . , The study shows how long-term pesticide ...
(Date:7/9/2014)... may be able to cope with the rising salinity of ... Arctic today is best known for its tundra and polar ... to 38 million years ago during what is known as ... huge temperate forest with brackish water, home to a variety ... and giant tortoises. Much of what is known about the ...
(Date:7/9/2014)... of Adlie penguins shows that the population is ... than previously estimated. Adlie penguins have long been ... understand the effects of climate change and fishing ... satellite imagery, researchers from Stony Brook University and ... that permits regular monitoring of Adlie penguins across ...
Breaking Biology News(10 mins):Bee foraging chronically impaired by pesticide exposure: Study 2Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3
... ON January 27, 2014 Cancer is the ... for about 30% of all deaths, according to the ... and effective drugs, it remains extremely difficult to develop ... looked at how to leverage current experimental therapies, in ...
... from Warwick Medical School have discovered a critical point of ... cell in the human body. The study, published today ... system is a key target for cancer drugs and, as ... be made. The tracks of this so called ,railway, are ...
... researchers have discovered the process by which high-density ... becomes dysfunctional, loses its cardio-protective properties, and instead ... hardening of the arteries. Their research was published ... . The beneficial and cardio-protective properties of ...
Cached Biology News:Ottawa researchers discover new combination therapy to kill cancer 2Cracks in the cellular transport system can be key to a new generation of cancer therapies 2Cleveland Clinic researchers discover process that turns 'good cholesterol' bad 2
...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
... reagent for Virus isolation ... unique water insoluble Elastomeric ... and chaotropes; Engineered to ... viruses while preserving infectivity; ...
Integrins Sampler Kit 10g each...
Biology Products: